nexa

OpenEvidence, an AI platform that helps doctors access evidence-based answers, has raised $210 million in Series B funding. The company says it now serves over 40% of U.S. physicians and plans to expand its tools and partnerships.

A couple’s 18-year battle with infertility ended in success thanks to a groundbreaking AI technology at Columbia University Fertility Center. The STAR method, which uses AI to detect rare sperm in samples where none are visible to the human eye, identified three viable sperm in the husband’s semen, enabling a successful IVF pregnancy. “It took…

The new AI system achieved 85% accuracy in diagnosing complex medical cases, surpassing the 20% accuracy of physicians. According to the company, it creates a path to medical superintelligence.

The new open-source tools aim to speed up early-stage drug development by predicting molecular interactions and optimizing candidates. Researchers worldwide are expected to benefit from broader access and collaboration.

A biotech startup has secured $22 million in Series C funding to advance its non-invasive cancer detection platform. Utilizing urine-based microRNA analysis, the company aims to facilitate early-stage diagnosis and expand its presence in the U.S. market.

Findings show that users often face difficulties getting clear or accurate health guidance from AI chatbots, highlighting concerns about their medical reliability.